Shanghai, China - 30 October, 2014 - CRONUS™ Surgical Stent Graft System ("CRONUS™"), an endovascular device of Shanghai MicroPort Medical (Group) Co., Ltd. ("MicroPort"), was recently granted the second prize of scientific and technological achievements by Pudong New Area Science and Technology Commission of Shanghai Municipality.

CRONUS™, self-developed by MicroPort's subsidiary MicroPort Endovascular (Shanghai) Co., Ltd., is mainly used in thoracic surgery for DeBakey I and DeBakey III aortic dissection. The device is specifically designed for the substitution of traditional stented elephant trunk procedure. The application of CRONUS™ vascular graft prosthesis has made the complex thoracic aortic surgery more convenient and safer, as it successfully combines traditional open surgery and advanced interventional approaches and significantly reduces the prevalence of morbidity and mortality.

CRONUS™ is one-of-a-kind in China and currently has 100% market share. It has been widely recognized within the medical industry and significantly improved the quality of surgical treatment of complex aortic dissections.

About MicroPort

MicroPort Scientific Corporation (the "Group") is a leading medical device company with business focusing on innovating, manufacturing, and marketing high-quality and high-end medical devices globally. With a diverse portfolio of products now being used at an average rate of one for every 20 seconds in thousands of major hospitals around the world, the Group maintains world-wide operations in a broad range of business segments including Cardiovascular, Orthopedic, Electrophysiological, Endovascular, Neurovascular, Surgical, Diabetes Care and Endocrinal Management, and others. MicroPort is dedicated to becoming a patient oriented global enterprise improve and reshape patient lives through application of innovative science and technology.

For more information, please refer to: www.microport.com

Forward-Looking Statements

Some information contained on this website contains forward-looking statements. These forward-looking statements include, without limitation, those regarding our future financial position, our strategy, plans, objectives, goals and targets, future developments in the markets where we participate or are seeking to participate, and any statements preceded by, followed by or that include the words "believe", "intend", "expect", anticipate", "project", "estimate", "predict", "is confident", "has confidence" and similar expressions are also intended to identify forward-looking statements. Such statements are based upon the current beliefs and expectations of MicroPort's management and are subject to significant risks and uncertainties. MicroPort Scientific Corporation undertakes no obligation to update any of the statements. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors that could cause actual future results to differ materially from current expectations include, but are not limited to, general industry and economic conditions, PRC governmental policies and regulations relating to the medical device manufacturing industry, competition in the medical device manufacturing industry, our ability to develop new products and stay abreast of market trends and technological advances, our goals and strategies, our ability to execute strategic acquisitions of, investments in or alliances with other companies and businesses, fluctuations in general economic and business conditions in China.

This document is for information purposes only and does not constitute or form part of any offer or invitation to sell or the solicitation of an offer or invitation to purchase or subscribe for any securities of MicroPort Scientific Corporation, and no part of it shall form the basis of, or be relied upon in connection with, any agreement, arrangement, contract, commitment or investment decision in relation thereto whatsoever.

All rights reserved.
Copyright © 2014 MicroPort Scientific Corporation

CONTACT:
Jonathan Chen
Senior Vice President, International Operations and Investor Relations
MicroPort Scientific Corporation
Tel: (86)(21) 38954600
Email: jonathanchen@microport.com
Xun You
Board Secretary
Shanghai MicroPort Medical (Group) Co., Ltd. (HQ)
Tel: (86)(21) 38954600-6959
Email: ir@microport.com
distributed by